{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:41:40Z","timestamp":1792071700742,"version":"4.4.0"},"reference-count":206,"publisher":"European Respiratory Society (ERS)","issue":"2","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publications.ersnet.org\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2025,10,25]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>Sarcoidosis is a complex systemic granulomatous disease that can affect multiple organs, with pulmonary involvement being the most common. Its pathogenesis involves genetic predisposition and chronic immune dysregulation, which increase susceptibility to environmental or endogenous triggers, leading to an aberrant immune response. Imaging plays a central role in diagnosis and has evolved from traditional chest radiography Scadding staging to a computed tomography-based classification and radiomics that improves disease phenotyping. Due to its variable presentation, diagnosing sarcoidosis and attributing symptoms to the disease can be challenging; therefore, awareness and consideration of alternative diagnoses remain essential. The clinical course of sarcoidosis is unpredictable; many patients do not require therapy. Treatment decisions must be individualised, balancing disease severity, risk of organ damage, quality of life and potential toxicity of medication. However, the lack of both reliable prognostic tools and clear criteria for high-risk cases contributes to substantial heterogeneity in disease management. While the guidelines still recommend corticosteroids as first-line treatment, recent data show that methotrexate and prednisone have comparable effects on pulmonary function, although differ in side-effect profiles and time to efficacy. For refractory cases, second-line therapy involves combining or switching drugs, with anti-tumour necrosis factor agents representing third-line options, ideally in expert hands. Novel therapies targeting pathways involved in disease pathogenesis are under investigation. There is growing consensus on the need to revise current treatment algorithms to minimise corticosteroid use and adopt more evidence-based approaches. Future priorities include identifying prognostic biomarkers, refining trial design and establishing meaningful end-points to improve individualised care for the heterogeneous population of patients with sarcoidosis.<\/jats:p>","DOI":"10.1183\/13993003.01324-2025","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T16:10:15Z","timestamp":1763050215000},"page":"2501324","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Sarcoidosis: a state-of-the-art review"],"prefix":"10.1183","volume":"67","author":[{"given":"Jelle R.","family":"Miedema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7579-9767","authenticated-orcid":false,"given":"Francesco","family":"Bonella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Buschulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4070-5569","authenticated-orcid":false,"given":"Florence","family":"Jeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4692-1345","authenticated-orcid":false,"given":"Ogugua Ndili","family":"Obi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1298-1243","authenticated-orcid":false,"given":"Natalia V.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Spagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Veltkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Wijsenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"2026021902501254000_67.2.2501324.1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2023.06.004","article-title":"Epidemiology of sarcoidosis","volume":"45","author":"Cozier","year":"2024","journal-title":"Clin Chest Med"},{"key":"2026021902501254000_67.2.2501324.2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12931-018-0871-3","article-title":"Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study","volume":"19","author":"Yoon","year":"2018","journal-title":"Respir Res"},{"key":"2026021902501254000_67.2.2501324.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00477-2016"},{"key":"2026021902501254000_67.2.2501324.4","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201511-760OC"},{"key":"2026021902501254000_67.2.2501324.5","doi-asserted-by":"crossref","first-page":"602419","DOI":"10.1183\/13993003.02419-2016","article-title":"Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris","volume":"50","author":"Duchemann","year":"2017","journal-title":"Eur Respir J"},{"key":"2026021902501254000_67.2.2501324.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2101555"},{"key":"2026021902501254000_67.2.2501324.7","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009096"},{"key":"2026021902501254000_67.2.2501324.8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2019.03.013","article-title":"Elderly sarcoidosis: a comparative study from a 42-year single-centre experience","volume":"152","author":"Rubio-Rivas","year":"2019","journal-title":"Respir Med"},{"key":"2026021902501254000_67.2.2501324.9","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00492-2022"},{"key":"2026021902501254000_67.2.2501324.10","doi-asserted-by":"crossref","first-page":"106828","DOI":"10.1016\/j.rmed.2022.106828","article-title":"Trends in sarcoidosis mortality rate in Japan from 2001 to 2020: a population-based study","volume":"196","author":"Harada","year":"2022","journal-title":"Respir Med"},{"key":"2026021902501254000_67.2.2501324.11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1164\/rccm.201906-1250OC","article-title":"Income and other contributors to poor outcomes in U.S. patients with sarcoidosis","volume":"201","author":"Harper","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021902501254000_67.2.2501324.12","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.00056201"},{"key":"2026021902501254000_67.2.2501324.13","doi-asserted-by":"crossref","first-page":"e0317237","DOI":"10.1371\/journal.pone.0317237","article-title":"Shifting temporal trends and disparities in sarcoidosis mortality in the United States: a retrospective analysis from 1999 to 2020","volume":"20","author":"Raza","year":"2025","journal-title":"PLoS One"},{"key":"2026021902501254000_67.2.2501324.14","doi-asserted-by":"crossref","first-page":"e031484","DOI":"10.1161\/JAHA.123.031484","article-title":"Trends and disparities in cardiovascular death in sarcoidosis: a population-based retrospective study in the United States from 1999 to 2020","volume":"13","author":"Tan","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026021902501254000_67.2.2501324.15","first-page":"1","article-title":"HLA genes: a hallmark of functional genetic variation and complex evolution","volume":"169","author":"Lenz","year":"2024","journal-title":"Methods Mol Biol"},{"key":"2026021902501254000_67.2.2501324.16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200303-459OC"},{"key":"2026021902501254000_67.2.2501324.17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1165\/rcmb.2014-0227OC","article-title":"Association of HLA-DRB1 with sarcoidosis susceptibility and progression in African Americans","volume":"53","author":"Levin","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026021902501254000_67.2.2501324.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201503-0418OC"},{"key":"2026021902501254000_67.2.2501324.19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043907"},{"key":"2026021902501254000_67.2.2501324.20","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201507-1372OC"},{"key":"2026021902501254000_67.2.2501324.21","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1489"},{"key":"2026021902501254000_67.2.2501324.22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202307-1291LE"},{"key":"2026021902501254000_67.2.2501324.23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1164\/rccm.202308-1331LE","article-title":"Genome and transcriptome-wide association study of fibrotic sarcoidosis in European Americans","volume":"209","author":"Liao","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021902501254000_67.2.2501324.24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202002-0251ST"},{"key":"2026021902501254000_67.2.2501324.25","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-100022"},{"key":"2026021902501254000_67.2.2501324.26","first-page":"455","article-title":"Seasonal clustering of sarcoidosis","volume":"2","author":"Bardinas","year":"1989","journal-title":"Lancet"},{"key":"2026021902501254000_67.2.2501324.27","first-page":"1052","article-title":"Geoepidemiological big data approach to sarcoidosis: geographical and ethnic determinants","volume":"37","author":"Brito-Zeron","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2026021902501254000_67.2.2501324.28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.rmed.2017.06.004","article-title":"Post-9\/11 sarcoidosis in WTC-exposed firefighters and emergency medical service workers","volume":"132","author":"Webber","year":"2017","journal-title":"Respir Med"},{"key":"2026021902501254000_67.2.2501324.29","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00197808"},{"key":"2026021902501254000_67.2.2501324.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038926"},{"key":"2026021902501254000_67.2.2501324.31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chest.2016.01.020","article-title":"Association between occupational exposures and sarcoidosis: an analysis from death certificates in the United States, 1988\u20131999","volume":"150","author":"Liu","year":"2016","journal-title":"Chest"},{"key":"2026021902501254000_67.2.2501324.32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.chest.2024.08.049","article-title":"The association between air pollution and lung function in sarcoidosis and implications for health disparities","volume":"167","author":"Mustafa","year":"2025","journal-title":"Chest"},{"key":"2026021902501254000_67.2.2501324.33","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1164\/rccm.202410-1925OC","article-title":"Particulate matter associations with lung function in pulmonary sarcoidosis","volume":"211","author":"Kim","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021902501254000_67.2.2501324.34","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0076-2021"},{"key":"2026021902501254000_67.2.2501324.35","doi-asserted-by":"crossref","first-page":"00930-2020","DOI":"10.1183\/23120541.00930-2020","article-title":"Detection of Cutibacterium acnes in granulomas of patients with either hypersensitivity pneumonitis or vasculitis reveals that its presence is not unique for sarcoidosis","volume":"7","author":"Beijer","year":"2021","journal-title":"ERJ Open Res"},{"key":"2026021902501254000_67.2.2501324.36","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.80"},{"key":"2026021902501254000_67.2.2501324.37","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00142-09"},{"key":"2026021902501254000_67.2.2501324.38","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90535-B"},{"key":"2026021902501254000_67.2.2501324.39","doi-asserted-by":"crossref","first-page":"e20210785","DOI":"10.1084\/jem.20210785","article-title":"CD4+ T cells in the lungs of acute sarcoidosis patients recognize an Aspergillus nidulans epitope","volume":"218","author":"Greaves","year":"2021","journal-title":"J Exp Med"},{"key":"2026021902501254000_67.2.2501324.40","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01209-2015"},{"key":"2026021902501254000_67.2.2501324.41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/MCP.0000000000000800","article-title":"Drug-induced sarcoidosis-like reactions","volume":"27","author":"Miedema","year":"2021","journal-title":"Curr Opin Pulm Med"},{"key":"2026021902501254000_67.2.2501324.42","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02051-2024"},{"key":"2026021902501254000_67.2.2501324.43","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00277-2024"},{"key":"2026021902501254000_67.2.2501324.44","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00157508"},{"key":"2026021902501254000_67.2.2501324.45","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1165\/rcmb.2015-0278OC","article-title":"Functional Toll-like receptor 9 expression and CXCR3 ligand release in pulmonary sarcoidosis","volume":"55","author":"Schnerch","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026021902501254000_67.2.2501324.46","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-008-9225-0"},{"key":"2026021902501254000_67.2.2501324.47","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3655"},{"key":"2026021902501254000_67.2.2501324.48","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00083002"},{"key":"2026021902501254000_67.2.2501324.49","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03468-2020"},{"key":"2026021902501254000_67.2.2501324.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103247"},{"key":"2026021902501254000_67.2.2501324.51","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01365.x"},{"key":"2026021902501254000_67.2.2501324.52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.1.642"},{"key":"2026021902501254000_67.2.2501324.53","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.1.9906071"},{"key":"2026021902501254000_67.2.2501324.54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805958"},{"key":"2026021902501254000_67.2.2501324.55","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2026021902501254000_67.2.2501324.56","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01124-2017"},{"key":"2026021902501254000_67.2.2501324.57","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201507-1499OC"},{"key":"2026021902501254000_67.2.2501324.58","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1164\/rccm.201503-0635LE","article-title":"Decreased cytotoxic T-lymphocyte antigen 4 expression on regulatory T cells and Th17 cells in sarcoidosis: double trouble?","volume":"192","author":"Broos","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021902501254000_67.2.2501324.59","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12931-015-0265-8","article-title":"Impaired survival of regulatory T cells in pulmonary sarcoidosis","volume":"16","author":"Broos","year":"2015","journal-title":"Respir Res"},{"key":"2026021902501254000_67.2.2501324.60","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.chest.2021.04.032","article-title":"Inhibiting OX40 restores regulatory T-cell function and suppresses inflammation in pulmonary sarcoidosis","volume":"160","author":"Kumari","year":"2021","journal-title":"Chest"},{"key":"2026021902501254000_67.2.2501324.61","doi-asserted-by":"crossref","first-page":"e178711","DOI":"10.1172\/JCI178711","article-title":"Recruitment of CXCR4+ type 1 innate lymphoid cells distinguishes sarcoidosis from other skin granulomatous diseases","volume":"134","author":"Sati","year":"2024","journal-title":"J Clin Invest"},{"key":"2026021902501254000_67.2.2501324.62","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202012-4423OC"},{"key":"2026021902501254000_67.2.2501324.63","doi-asserted-by":"publisher","DOI":"10.1016\/J.IMMUNI.2023.01.014"},{"key":"2026021902501254000_67.2.2501324.64","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00991-2017"},{"key":"2026021902501254000_67.2.2501324.65","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.10.2104046"},{"key":"2026021902501254000_67.2.2501324.66","doi-asserted-by":"crossref","first-page":"107608","DOI":"10.1016\/j.rmed.2024.107608","article-title":"Organ involvement in newly diagnosed sarcoidosis patients in the Netherlands: the first large European multicentre prospective study","volume":"226","author":"Van Woensel","year":"2024","journal-title":"Respir Med"},{"key":"2026021902501254000_67.2.2501324.67","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-214348"},{"key":"2026021902501254000_67.2.2501324.68","doi-asserted-by":"crossref","first-page":"105998","DOI":"10.1016\/j.rmed.2020.105998","article-title":"Clinical features and outcomes of asymptomatic pulmonary sarcoidosis. A comparative cohort study","volume":"169","author":"Iriarte","year":"2020","journal-title":"Respir Med"},{"key":"2026021902501254000_67.2.2501324.69","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200807-1082OC"},{"key":"2026021902501254000_67.2.2501324.70","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01160-2020"},{"key":"2026021902501254000_67.2.2501324.71","doi-asserted-by":"crossref","first-page":"577864","DOI":"10.1016\/j.jneuroim.2022.577864","article-title":"Peripheral neuropathy in sarcoidosis","volume":"368","author":"Tavee","year":"2022","journal-title":"J Neuroimmunol"},{"key":"2026021902501254000_67.2.2501324.72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00005382-199004000-00010","article-title":"Hilar and mediastinal adenopathy in sarcoidosis as detected by computed tomography","volume":"5","author":"Sider","year":"1990","journal-title":"J Thorac Imaging"},{"key":"2026021902501254000_67.2.2501324.73","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2479"},{"key":"2026021902501254000_67.2.2501324.74","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-004-2480-4"},{"key":"2026021902501254000_67.2.2501324.75","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9260(96)80343-6"},{"key":"2026021902501254000_67.2.2501324.76","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-0037-1603765","article-title":"Imaging for sarcoidosis","volume":"38","author":"Calandriello","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"key":"2026021902501254000_67.2.2501324.77","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00025212"},{"key":"2026021902501254000_67.2.2501324.78","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.042838"},{"key":"2026021902501254000_67.2.2501324.79","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s00330-024-10949-4","article-title":"Meta-analysis of [18F]FDG-PET\/CT in pulmonary sarcoidosis","volume":"35","author":"Donnelly","year":"2025","journal-title":"Eur Radiol"},{"key":"2026021902501254000_67.2.2501324.80","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.5823"},{"key":"2026021902501254000_67.2.2501324.81","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-2339"},{"key":"2026021902501254000_67.2.2501324.82","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.02101"},{"key":"2026021902501254000_67.2.2501324.83","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.1.109"},{"key":"2026021902501254000_67.2.2501324.84","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.3390\/jcm10235686","article-title":"Diagnostic yield of transbronchial lung cryobiopsy compared to transbronchial forceps biopsy in patients with sarcoidosis in a prospective, randomized, multicentre cross-over trial","volume":"10","author":"Hantschel","year":"2021","journal-title":"J Clin Med"},{"key":"2026021902501254000_67.2.2501324.85","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.rmed.2017.08.003","article-title":"The complimentary role of transbronchial lung cryobiopsy and endobronchial ultrasound fine needle aspiration in the diagnosis of sarcoidosis","volume":"131","author":"Aragaki-Nakahodo","year":"2017","journal-title":"Respir Med"},{"key":"2026021902501254000_67.2.2501324.86","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0012-2017"},{"key":"2026021902501254000_67.2.2501324.87","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201010-1679OC"},{"key":"2026021902501254000_67.2.2501324.88","first-page":"167","article-title":"Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"2026021902501254000_67.2.2501324.89","doi-asserted-by":"crossref","first-page":"106564","DOI":"10.1016\/j.rmed.2021.106564","article-title":"The impact of demographic disparities in the presentation of sarcoidosis: a multicenter prospective study","volume":"187","author":"Zhou","year":"2021","journal-title":"Respir Med"},{"key":"2026021902501254000_67.2.2501324.90","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12890-020-01191-x","article-title":"Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts","volume":"20","author":"Te","year":"2020","journal-title":"BMC Pulm Med"},{"key":"2026021902501254000_67.2.2501324.91","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1993.tb01148.x"},{"key":"2026021902501254000_67.2.2501324.92","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1177\/1925362118797744","article-title":"Cardiac involvement in sarcoidosis deaths in Wayne County, Michigan: a 20-year retrospective study","volume":"8","author":"Webb","year":"2018","journal-title":"Acad Forensic Pathol"},{"key":"2026021902501254000_67.2.2501324.93","first-page":"275","article-title":"Causes of death in patients with chronic sarcoidosis","volume":"33","author":"Hu","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021902501254000_67.2.2501324.94","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.011522"},{"key":"2026021902501254000_67.2.2501324.95","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/ehf2.12853","article-title":"Diagnosis of isolated cardiac sarcoidosis based on new guidelines","volume":"7","author":"Kawai","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026021902501254000_67.2.2501324.96","doi-asserted-by":"publisher","DOI":"10.1111\/jce.12401"},{"key":"2026021902501254000_67.2.2501324.97","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ejhf.1319","article-title":"Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres","volume":"20","author":"Fussner","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026021902501254000_67.2.2501324.98","doi-asserted-by":"publisher","DOI":"10.1111\/pace.12277"},{"key":"2026021902501254000_67.2.2501324.99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.042"},{"key":"2026021902501254000_67.2.2501324.100","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.03.043"},{"key":"2026021902501254000_67.2.2501324.101","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad067"},{"key":"2026021902501254000_67.2.2501324.102","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz428"},{"key":"2026021902501254000_67.2.2501324.103","doi-asserted-by":"crossref","first-page":"e006145","DOI":"10.1161\/CIRCEP.117.006145","article-title":"Outcome of cardiac sarcoidosis presenting with high-grade atrioventricular block","volume":"11","author":"Nordenswan","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026021902501254000_67.2.2501324.104","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.11.028"},{"key":"2026021902501254000_67.2.2501324.105","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001240"},{"key":"2026021902501254000_67.2.2501324.106","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12350-017-1043-4","article-title":"A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology","volume":"25","author":"Slart","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"2026021902501254000_67.2.2501324.107","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.115.003738"},{"key":"2026021902501254000_67.2.2501324.108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.09.022"},{"key":"2026021902501254000_67.2.2501324.109","doi-asserted-by":"crossref","first-page":"e222483","DOI":"10.1148\/radiol.222483","article-title":"Prognostic value of cardiac MRI and FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis","volume":"307","author":"Aitken","year":"2023","journal-title":"Radiology"},{"key":"2026021902501254000_67.2.2501324.110","doi-asserted-by":"crossref","first-page":"101842","DOI":"10.1016\/j.nuclcard.2024.101842","article-title":"Role of serial 18F-fludeoxyglucose positron emission tomography in determining the therapeutic efficacy of immunosuppression and clinical outcome in patients with cardiac sarcoidosis","volume":"35","author":"Okafor","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"2026021902501254000_67.2.2501324.111","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-19-0508"},{"key":"2026021902501254000_67.2.2501324.112","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021902501254000_67.2.2501324.113","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ccm.2023.08.006","article-title":"Cardiac sarcoidosis","volume":"45","author":"Ribeiro Neto","year":"2024","journal-title":"Clin Chest Med"},{"key":"2026021902501254000_67.2.2501324.114","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCGEN.123.004099","article-title":"Cardiac sarcoidosis mimickers: genetic testing in undifferentiated inflammatory cardiomyopathies","volume":"16","author":"Castrichini","year":"2023","journal-title":"Circ Genom Precis Med"},{"key":"2026021902501254000_67.2.2501324.115","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jce.15191","article-title":"Electrogram-guided endomyocardial biopsy yield in patients with suspected cardiac sarcoidosis and relation to outcomes","volume":"32","author":"Ezzeddine","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026021902501254000_67.2.2501324.116","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/s-0037-1604165","article-title":"Neurosarcoidosis","volume":"38","author":"Culver","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"key":"2026021902501254000_67.2.2501324.117","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MAO.0000000000000501","article-title":"Cranial base manifestations of neurosarcoidosis: a review of 305 patients","volume":"36","author":"Carlson","year":"2015","journal-title":"Otol Neurotol"},{"key":"2026021902501254000_67.2.2501324.118","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0741-x"},{"key":"2026021902501254000_67.2.2501324.119","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0b013e3182704d04"},{"key":"2026021902501254000_67.2.2501324.120","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jamaneurol.2018.2295","article-title":"Definition and consensus diagnostic criteria for neurosarcoidosis: from the Neurosarcoidosis Consortium Consensus Group","volume":"75","author":"Stern","year":"2018","journal-title":"JAMA Neurol"},{"key":"2026021902501254000_67.2.2501324.121","doi-asserted-by":"crossref","first-page":"103288","DOI":"10.1016\/j.jaut.2024.103288","article-title":"A framework for exclusion of alternative diagnoses in sarcoidosis","volume":"149","author":"Harper","year":"2024","journal-title":"J Autoimmun"},{"key":"2026021902501254000_67.2.2501324.122","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00408-018-0144-4","article-title":"Needs, perceptions and education in sarcoidosis: a live interactive survey of patients and partners","volume":"196","author":"Moor","year":"2018","journal-title":"Lung"},{"key":"2026021902501254000_67.2.2501324.123","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00408-024-00761-8","article-title":"A snapshot of United States sarcoidosis patients and their perceived disease impact: results of the Sarcoidosis Research Institute Survey","volume":"203","author":"Obi","year":"2025","journal-title":"Lung"},{"key":"2026021902501254000_67.2.2501324.124","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00408-019-00206-7","article-title":"The burden of sarcoidosis symptoms from a patient perspective","volume":"197","author":"Voortman","year":"2019","journal-title":"Lung"},{"key":"2026021902501254000_67.2.2501324.125","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2629"},{"key":"2026021902501254000_67.2.2501324.126","doi-asserted-by":"publisher","DOI":"10.1348\/1359107041557048"},{"key":"2026021902501254000_67.2.2501324.127","doi-asserted-by":"publisher","DOI":"10.1159\/000092670"},{"key":"2026021902501254000_67.2.2501324.128","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.rmed.2017.11.008","article-title":"Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: a prospective follow-up study","volume":"138S","author":"Hendriks","year":"2018","journal-title":"Respir Med"},{"key":"2026021902501254000_67.2.2501324.129","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.02080"},{"key":"2026021902501254000_67.2.2501324.130","first-page":"169","article-title":"Obstructive sleep apnea in sarcoidosis and impact of CPAP treatment on fatigue","volume":"37","author":"Mari","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021902501254000_67.2.2501324.131","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s11325-021-02513-x","article-title":"Clinical and polysomnographic evaluation of sleep-related breathing disorders in patients with sarcoidosis","volume":"26","author":"Ataoglu","year":"2022","journal-title":"Sleep Breath"},{"key":"2026021902501254000_67.2.2501324.132","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00002512"},{"key":"2026021902501254000_67.2.2501324.133","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/JND-200490","article-title":"Current view of diagnosing small fiber neuropathy","volume":"8","author":"Raasing","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"2026021902501254000_67.2.2501324.134","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181bacf05"},{"key":"2026021902501254000_67.2.2501324.135","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.chest.2024.07.159","article-title":"Sexual dysfunction in patients with sarcoidosis","volume":"166","author":"Moor","year":"2024","journal-title":"Chest"},{"key":"2026021902501254000_67.2.2501324.136","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/14737175.2020.1794825","article-title":"Clinical diagnosis and management of small fiber neuropathy: an update on best practice","volume":"20","author":"Devigili","year":"2020","journal-title":"Expert Rev Neurother"},{"key":"2026021902501254000_67.2.2501324.137","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2010.09.014"},{"key":"2026021902501254000_67.2.2501324.138","first-page":"56","article-title":"Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force","volume":"28","author":"Baughman","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021902501254000_67.2.2501324.139","first-page":"124","article-title":"Hospitalization for patients with sarcoidosis: 1979\u20132000","volume":"23","author":"Foreman","year":"2006","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021902501254000_67.2.2501324.140","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-12-19"},{"key":"2026021902501254000_67.2.2501324.141","first-page":"204","article-title":"Two year prognosis of sarcoidosis: the ACCESS experience","volume":"20","author":"Judson","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021902501254000_67.2.2501324.142","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021902501254000_67.2.2501324.143","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00070503"},{"key":"2026021902501254000_67.2.2501324.144","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejim.2022.11.020","article-title":"Systemic treatment in sarcoidosis: experience over two decades","volume":"108","author":"Fernandez-Ramon","year":"2023","journal-title":"Eur J Intern Med"},{"key":"2026021902501254000_67.2.2501324.145","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0085-2023"},{"key":"2026021902501254000_67.2.2501324.146","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1164\/rccm.202106-1366CI","article-title":"Management of advanced pulmonary sarcoidosis","volume":"205","author":"Gupta","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021902501254000_67.2.2501324.147","doi-asserted-by":"crossref","first-page":"103397","DOI":"10.1016\/j.jaut.2025.103397","article-title":"Advanced pulmonary sarcoidosis","volume":"152","author":"Jeny","year":"2025","journal-title":"J Autoimmun"},{"key":"2026021902501254000_67.2.2501324.148","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00226911"},{"key":"2026021902501254000_67.2.2501324.149","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00057-3"},{"key":"2026021902501254000_67.2.2501324.150","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02396-2016"},{"key":"2026021902501254000_67.2.2501324.151","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00897-2019"},{"key":"2026021902501254000_67.2.2501324.152","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02223-2019"},{"key":"2026021902501254000_67.2.2501324.153","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00187410"},{"key":"2026021902501254000_67.2.2501324.154","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03358-2020"},{"key":"2026021902501254000_67.2.2501324.155","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0165-2021"},{"key":"2026021902501254000_67.2.2501324.156","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00083404"},{"key":"2026021902501254000_67.2.2501324.157","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00465-2017"},{"key":"2026021902501254000_67.2.2501324.158","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01747-2019"},{"key":"2026021902501254000_67.2.2501324.159","doi-asserted-by":"publisher","DOI":"10.1002\/pul2.12297"},{"key":"2026021902501254000_67.2.2501324.160","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1766"},{"key":"2026021902501254000_67.2.2501324.161","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.chest.2021.07.2162","article-title":"Riociguat for sarcoidosis-associated pulmonary hypertension: results of a 1-year double-blind, placebo-controlled trial","volume":"161","author":"Baughman","year":"2022","journal-title":"Chest"},{"key":"2026021902501254000_67.2.2501324.162","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04079-2020"},{"key":"2026021902501254000_67.2.2501324.163","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2015.08.015"},{"key":"2026021902501254000_67.2.2501324.164","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00198-2023"},{"key":"2026021902501254000_67.2.2501324.165","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir Med"},{"key":"2026021902501254000_67.2.2501324.166","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.10.1301"},{"key":"2026021902501254000_67.2.2501324.167","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMoa2501443","article-title":"First-line treatment of pulmonary sarcoidosis with prednisone or methotrexate","volume":"393","author":"Kahlmann","year":"2025","journal-title":"N Engl J Med"},{"key":"2026021902501254000_67.2.2501324.168","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMe2504736","article-title":"Methotrexate as initial therapy for symptomatic pulmonary sarcoidosis?","volume":"393","author":"Baughman","year":"2025","journal-title":"N Engl J Med"},{"key":"2026021902501254000_67.2.2501324.169","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1728"},{"key":"2026021902501254000_67.2.2501324.170","first-page":"43","article-title":"Leflunomide for chronic sarcoidosis","volume":"21","author":"Baughman","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021902501254000_67.2.2501324.171","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2014.09.013"},{"key":"2026021902501254000_67.2.2501324.172","first-page":"e2024039","article-title":"Hydroxychloroquine monotherapy in sarcoidosis: Indications, efficacy, and side effects","volume":"41","author":"Vermeer","year":"2024","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021902501254000_67.2.2501324.173","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2022.1570","article-title":"Diagnosis and treatment of pulmonary sarcoidosis: a review","volume":"327","author":"Belperio","year":"2022","journal-title":"JAMA"},{"key":"2026021902501254000_67.2.2501324.174","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"key":"2026021902501254000_67.2.2501324.175","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.10.014"},{"key":"2026021902501254000_67.2.2501324.176","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200603-402OC"},{"key":"2026021902501254000_67.2.2501324.177","first-page":"201","article-title":"A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis","volume":"23","author":"Rossman","year":"2006","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021902501254000_67.2.2501324.178","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-223014"},{"key":"2026021902501254000_67.2.2501324.179","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00227014"},{"key":"2026021902501254000_67.2.2501324.180","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00055213"},{"key":"2026021902501254000_67.2.2501324.181","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.rmed.2018.02.009","article-title":"Efficacy and safety of infliximab biosimilar Inflectra in severe sarcoidosis","volume":"138S","author":"Schimmelpennink","year":"2018","journal-title":"Respir Med"},{"key":"2026021902501254000_67.2.2501324.182","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1973.107.4.609"},{"key":"2026021902501254000_67.2.2501324.183","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.3.238"},{"key":"2026021902501254000_67.2.2501324.184","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(67)90493-X"},{"key":"2026021902501254000_67.2.2501324.185","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00767-2020"},{"key":"2026021902501254000_67.2.2501324.186","first-page":"217","article-title":"Effectiveness and tolerability of methotrexate in pulmonary sarcoidosis: a single center real-world study","volume":"36","author":"Fang","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021902501254000_67.2.2501324.187","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430080088011"},{"key":"2026021902501254000_67.2.2501324.188","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/resp.14001","article-title":"Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: a retrospective \u2018target trial\u2019 emulated with Swedish real-world data","volume":"26","author":"Rossides","year":"2021","journal-title":"Respirology"},{"key":"2026021902501254000_67.2.2501324.189","first-page":"e2020001","article-title":"Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period","volume":"37","author":"Baughman","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021902501254000_67.2.2501324.190","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.10.005"},{"key":"2026021902501254000_67.2.2501324.191","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s11845-015-1363-9","article-title":"Adalimumab for refractory pulmonary sarcoidosis","volume":"185","author":"Minnis","year":"2016","journal-title":"Ir J Med Sci"},{"key":"2026021902501254000_67.2.2501324.192","first-page":"46","article-title":"Efficacy results of a 52-week trial of adalimumab in the treatment of refractory sarcoidosis","volume":"31","author":"Sweiss","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021902501254000_67.2.2501324.193","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/jcm9020390","article-title":"Comprehensive care for patients with sarcoidosis","volume":"9","author":"Moor","year":"2020","journal-title":"J Clin Med"},{"key":"2026021902501254000_67.2.2501324.194","doi-asserted-by":"crossref","first-page":"103123","DOI":"10.1016\/j.jaut.2023.103123","article-title":"Quality of life in sarcoidosis","volume":"149","author":"Moor","year":"2024","journal-title":"J Autoimmun"},{"key":"2026021902501254000_67.2.2501324.195","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/17476348.2016.1227244","article-title":"Physical activity and training in sarcoidosis: review and experience-based recommendations","volume":"10","author":"Strookappe","year":"2016","journal-title":"Expert Rev Respir Med"},{"key":"2026021902501254000_67.2.2501324.196","first-page":"53","article-title":"Does physical training reduce fatigue in sarcoidosis?","volume":"32","author":"Marcellis","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021902501254000_67.2.2501324.197","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S2213-2600(22)00387-3","article-title":"Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trial","volume":"11","author":"Kahlmann","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2026021902501254000_67.2.2501324.198","doi-asserted-by":"crossref","first-page":"101062","DOI":"10.1016\/j.conctc.2023.101062","article-title":"Design and rationale of a pilot randomized clinical trial investigating the use of a mHealth app for sarcoidosis-associated fatigue","volume":"32","author":"Chandler","year":"2023","journal-title":"Contemp Clin Trials Commun"},{"key":"2026021902501254000_67.2.2501324.199","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MCP.0000000000001202","article-title":"Deciphering sarcoidosis immunopathogenesis through systems biology","volume":"31","author":"Jbeli","year":"2025","journal-title":"Curr Opin Pulm Med"},{"key":"2026021902501254000_67.2.2501324.200","doi-asserted-by":"crossref","first-page":"2002950","DOI":"10.1183\/13993003.02950-2020","article-title":"Transcriptomics of bronchoalveolar lavage cells identifies new molecular endotypes of sarcoidosis","volume":"58","author":"Vukmirovic","year":"2021","journal-title":"Eur Respir J"},{"key":"2026021902501254000_67.2.2501324.201","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S2213-2600(23)00267-9","article-title":"High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study","volume":"12","author":"Desai","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2026021902501254000_67.2.2501324.202","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/MCP.0000000000000902","article-title":"Quantitative computed tomography and machine learning: recent data in fibrotic interstitial lung disease and potential role in pulmonary sarcoidosis","volume":"28","author":"Wells","year":"2022","journal-title":"Curr Opin Pulm Med"},{"key":"2026021902501254000_67.2.2501324.203","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.10.037"},{"key":"2026021902501254000_67.2.2501324.204","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30615-x"},{"key":"2026021902501254000_67.2.2501324.205","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S2665-9913(23)00302-8","article-title":"Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial","volume":"6","author":"Redl","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"2026021902501254000_67.2.2501324.206","unstructured":"aTyr Pharma . aTyr Pharma presents additional findings from phase 3 EFZO-FIT study in late-breaking oral abstract at the European Respiratory Society (ERS) Congress 2025. 2025. https:\/\/investors.atyrpharma.com\/news-releases\/news-release-details\/atyr-pharma-presents-additional-findings-phase-3-efzo-fittm Date last accessed: 7 November 2025."}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01324-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T10:50:32Z","timestamp":1771498232000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01324-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":206,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,19]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1183\/13993003.01324-2025"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01324-2025","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}